Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Exclusion Criteria

• •A. Clinical criteria
• •1. Acute critical limb ischemia
• •2. Severe critical limb ischemia (Rutherford category 6)
• •3. Major bleeding history within prior 2 months
• •4. Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel or contrast agents
• •5. Age \> 85 years
• •6. Severe hepatic dysfunction (\> 3 times normal reference values)
• •7. Significant renal dysfunction (Serum creatinine \> 2.0 mg/dl
• •8. Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
• •9. LVEF(left ventricular ejection fraction) \<40% or clinically overt congestive heart failure
• •10. Pregnant women or women with potential childbearing
• •11. Life expectancy \<1 year due to comorbidity
• •Angiographic criteria
• •1. Previous bypass surgery or stenting of the superficial femoral artery
• •2. Untreated inflow disease of the ipsilateral pelvic arteries (more than 50%stenosis or or occlusion
• •3. Popliteal artery stenosis \>50% at P2 or P3 segment